COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Saber Soltani ◽  
Alireza Tabibzadeh ◽  
Armin Zakeri ◽  
Amir Mohammad Zakeri ◽  
Tayebeh Latifi ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Viral Infections ◽  
Psychological Symptoms ◽  
Meta Analysis ◽  
Olfactory Dysfunction ◽  
Neurological Symptoms ◽  
Online Databases ◽  
Pooled Prevalence ◽  
Wide Range

Abstract The ongoing pandemic of Coronavirus disease 2019 (COVID-19) has infected more than 27 million confirmed cases and 8,90,000 deaths all around the world. Verity of viral infections can infect the nervous system; these viral infections can present a wide range of manifestation. The aim of the current study was to systematically review the COVID-19 associated central nervous system manifestations, mental and neurological symptoms. For that we conducted a comprehensive systematic literature review of four online databases, including Web of Science, PubMed, Scopus and Embase. All relevant articles that reported psychiatric/psychological symptoms or disorders in COVID-19 without considering time and language restrictions were assessed. All the study procedures were performed based on the PRISMA criteria. Due to the screening, 14 studies were included. The current study result indicated that, the pooled prevalence of CNS or mental associated disorders with 95% CI was 50.68% (6.68–93.88). The most prevalence symptoms were hyposmia/anosmia/olfactory dysfunction (number of study: 10) with 36.20% (14.99–60.51). Only one study reported numbness/paresthesia and dysphonia. Pooled prevalence of numbness/paresthesia and dysphonia was 5.83% (2.17–12.25) and 2.39% (10.75–14.22). The pooled prevalence of depression and anxiety was 3.52% (2.62–4.54) and 13.92% (9.44–19.08). Our findings demonstrate that COVID-19 has a certain relation with neurological symptoms. The hypsomia, anosmia or olfactory dysfunction was most frequent symptom. Other symptoms were headache or dizziness, dysgeusia or ageusia, dysphonia and fatigue. Depression, anxiety, and confusion were less frequent symptoms.

Covid 19 Associated Smell Disturbances

2021 ◽  
Vol 19 (8) ◽  
pp. 84-87
Author(s):  
Mazin Rajeh Jaber
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Viral Infections ◽  
Central Nervous System Involvement ◽  
Upper Respiratory Tract ◽  
Positive Polymerase Chain Reaction ◽  
Wide Range ◽  
Tract Infections ◽  
A Prospective Study ◽  
Age Range

Background: Smell disturbances are associated with wide range of viral infections. Viral upper respiratory tract infections may cause acute Smell loss due to viral damage to the olfactory epithelium or central nervous system involvement is a possible causes of smell disturbances but, the exact pathogenesis unknown. Aim of the study: assess the Covid 19 associated smell disturbances. Method: This is a prospective study consisted of 200 patients with a confirmed COVID-19 infection, who treated in Al-Diwanyah pandemic hospital in Al-Diwanyah city, Iraq, between July 2020 and May 2021.They were 115 males and 85 females. The age range from 20-80 years. The inclusion criteria were symptomatic patients with positive polymerase chain reaction (PCR) test for COVID-19 infection. Exclusion criteria were any physical, neurological or mental diseases preventing cooperation of the patients, use of central nervous system suppressing drugs. Results: We found that 36 % of patients developed smell disturbances. Most of those affected patients are above 60 years old and majority are females (58.3%). 33.3 % of patients present with isolated smell disturbances without any other features. The time for recovery of smell disturbances ranged from 7- 21 days, and the median time for recovery was 7 days. 8.3 % of patients develop persistent smell problems. Conclusion: Smell abnormalities are common symptoms in COVID-19 patients. It may be the only manifestation of COVID-19.

Infections of the Central Nervous System

2018 ◽  
pp. 122-158 ◽  
Author(s):  
Fabrice Chrétien ◽  
Gregory Jouvion ◽  
Kum Thong Wong ◽  
Leroy R. Sharer
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Viral Infections ◽  
Opportunistic Infections ◽  
Modern World ◽  
Parasitic Infections ◽  
System P ◽  
Wide Range ◽  
The Central Nervous System ◽  
Specific Agent

This chapter describes and illustrates the different lesions observed in central nervous system (CNS) infections. A wide variety of pathogenic infectious organisms may affect the CNS. They can be classified as pathogenic (causing diseases in every individual) or opportunistic (only affecting patients with impaired immune defenses). Bacteria may cause pyogenic infections or so-called specific infections in which the morphology of the lesions suggest a specific agent. Mycoses and parasitic infections were relatively uncommon and restricted to certain countries; however, due many factors in the modern world, including, for example, immunodeficiency of various causes and intercontinental travel, they are now more frequently encountered. Viral infections of the CNS cause lesions due to immunoallergic reactions or specific encephalitides. In AIDS, infection by HIV causes a unique encephalitis and immunodeficiency with a wide range of secondary opportunistic infections.

DIAGNOSTIC VALUE OF SPECIFIC ANTIBODY SYNTHESIS IN BRAIN OF PATIENTS WITH NEUROINFECTIONS

2019 ◽  
Vol 72 (8) ◽  
pp. 1437-1441
Author(s):  
Pavel Dyachenko ◽  
Igor Filchakov ◽  
Anatoly Dyachenko ◽  
Victoria Kurhanskaya
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Clinical Manifestations ◽  
Diagnostic Value ◽  
Diagnostic Challenge ◽  
Specific Antibodies ◽  
Intrathecal Synthesis ◽  
Varicella Zoster ◽  
Mrz Reaction ◽  
Wide Range

Introduction: Viral encephalitis accounts for 40-70% of all cases worldwide, central nervous system infections pose a diagnostic challenge because clinical manifestations are not typically pathognomonic for specific pathogens, and a wide range of agents can be causative. The aim: To assess the diagnostic value of intrathecal synthesis of specific antibodies in patients with inflammatory lesions of the central nervous system. Materials and methods: Within the framework of the study, two groups of 90 people in each were formed from the patients with neuroinfections admitted to our Center. Intrathecal synthesis (ITS) of total (unspecific) IgG in members of one of group (group of compare) was determined. Brain synthesis of specific antibodies (Ab) to some neurotropic pathogens (herpes simplex virus 1/2, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, rubella virus, Borrelies) was studied in the second group of patients (group of interest). There were no statistically significant differences between groups by gender and age. Encephalitis and encephalomyelitis prevailed among patients of both groups Results: ITS of total IgG was established in 30 (33.3 ± 6.1 %) patients of the first group with IgG index more than 0.6 indicating on inflammatory process in CNS and no marked changes of CSF. ITS of specific Ab was determined in 23 of 90 (25.6 ± 4.6 %) patients included into group of interest. In more than half of cases Ab to several infectious agents were detected simultaneously. ITS of various specificity, in particular, to measles and rubella viruses, and VZV, known as MRZ-reaction, is characteristic of some autoimmune lesions of CNS, multiple sclerosis first of all. In fact, further research of 5 patients with MRZ-reaction confirmed their autoimmune failure of CNS. Detection of ITS in the CSF samples didn’t depend on concentration of specific Ab in serum and CSF and wasn’t followed by HEB dysfunctions which were observed with the same frequency in patients with or without ITS (13.0 % and 13.6 % respectively). Conclusion: Specific Ab synthesis to several neurotropic pathogens in the CSF of significant part of examined patients was established. Thus, diagnostic value of ITS of specific immunoglobulins seems to be limited to cases in which autoimmune damage of the CNS is suspected.

scholarly journals Leap Motion Controller Video Game-Based Therapy for Upper Extremity Motor Recovery in Patients with Central Nervous System Diseases. A Systematic Review with Meta-Analysis

Sensors ◽  
2021 ◽  
Vol 21 (6) ◽  
pp. 2065
Author(s):  
Irene Cortés-Pérez ◽  
Noelia Zagalaz-Anula ◽  
Desirée Montoro-Cárdenas ◽  
Rafael Lomas-Vega ◽  
Esteban Obrero-Gaitán ◽  
...  
Keyword(s):  
Systematic Review ◽  
Central Nervous System ◽  
Nervous System ◽  
Motor Function ◽  
Video Game ◽  
Meta Analysis ◽  
Leap Motion ◽  
Motion Controller ◽  
Motor Dexterity ◽  
Quality Evidence

Leap Motion Controller (LMC) is a virtual reality device that can be used in the rehabilitation of central nervous system disease (CNSD) motor impairments. This review aimed to evaluate the effect of video game-based therapy with LMC on the recovery of upper extremity (UE) motor function in patients with CNSD. A systematic review with meta-analysis was performed in PubMed Medline, Web of Science, Scopus, CINAHL, and PEDro. We included five randomized controlled trials (RCTs) of patients with CNSD in which LMC was used as experimental therapy compared to conventional therapy (CT) to restore UE motor function. Pooled effects were estimated with Cohen’s standardized mean difference (SMD) and its 95% confidence interval (95% CI). At first, in patients with stroke, LMC showed low-quality evidence of a large effect on UE mobility (SMD = 0.96; 95% CI = 0.47, 1.45). In combination with CT, LMC showed very low-quality evidence of a large effect on UE mobility (SMD = 1.34; 95% CI = 0.49, 2.19) and the UE mobility-oriented task (SMD = 1.26; 95% CI = 0.42, 2.10). Second, in patients with non-acute CNSD (cerebral palsy, multiple sclerosis, and Parkinson’s disease), LMC showed low-quality evidence of a medium effect on grip strength (GS) (SMD = 0.47; 95% CI = 0.03, 0.90) and on gross motor dexterity (GMD) (SMD = 0.73; 95% CI = 0.28, 1.17) in the most affected UE. In combination with CT, LMC showed very low-quality evidence of a high effect in the most affected UE on GMD (SMD = 0.80; 95% CI = 0.06, 1.15) and fine motor dexterity (FMD) (SMD = 0.82; 95% CI = 0.07, 1.57). In stroke, LMC improved UE mobility and UE mobility-oriented tasks, and in non-acute CNSD, LMC improved the GS and GMD of the most affected UE and FMD when it was used with CT.

scholarly journals Pre and Probiotics Involved in the Modulation of Oral Bacterial Species: New Therapeutic Leads in Mental Disorders?

2021 ◽  
Vol 9 (7) ◽  
pp. 1450
Author(s):  
Yoann Maitre ◽  
Rachid Mahalli ◽  
Pierre Micheneau ◽  
Alexis Delpierre ◽  
Marie Guerin ◽  
...  
Keyword(s):  
Systematic Review ◽  
Central Nervous System ◽  
Nervous System ◽  
Oral Health ◽  
Mental Disorders ◽  
Meta Analysis ◽  
Bacterial Species ◽  
Oral Microbiome ◽  
Oral Microbiota ◽  
Therapeutic Leads

This systematic review aims to identify probiotics and prebiotics for modulating oral bacterial species associated with mental disorders. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guideline, we search the electronic MEDLINE database published till January 2021 to identify the studies on probiotics and/or prebiotics for preventing and treating major oral dysbiosis that provokes mental disorders. The outcome of the search produces 374 records. After excluding non-relevant studies, 38 papers were included in the present review. While many studies suggest the potential effects of the oral microbiota on the biochemical signalling events between the oral microbiota and central nervous system, our review highlights the limited development concerning the use of prebiotics and/or probiotics in modulating oral dysbiosis potentially involved in the development of mental disorders. However, the collected studies confirm prebiotics and/or probiotics interest for a global or targeted modulation of the oral microbiome in preventing or treating mental disorders. These outcomes also offer exciting prospects for improving the oral health of people with mental disorders in the future.

scholarly journals Central nervous system manifestations in COVID‐19 patients: A systematic review and meta‐analysis

2021 ◽  
Author(s):  
Shahrzad Nazari ◽  
Amirhossein Azari Jafari ◽  
Seyyedmohammadsadeq Mirmoeeni ◽  
Saeid Sadeghian ◽  
Mohammad Eghbal Heidari ◽  
...  
Keyword(s):  
Systematic Review ◽  
Central Nervous System ◽  
Nervous System ◽  
Meta Analysis
Sign in / Sign up

Export Citation Format

Share Document